Abstract
Cannabis use is common in youth and there is evidence that the co-occurrence of cannabis use (and other substance use) with mental illnesses predicts poorer outcomes, including suicide. The main purposes of this study were to: (i) identify rates of cannabis use and substance use disorder risk, and (ii) predictors for cannabis use among youth seeking help for mood and/or anxiety concerns in a sample population prescreened to exclude primary substance use disorders; and (iii) to determine if there was an association between cannabis use and functional impairment in this sample. We investigated substance use risk as well as hypothesized predictors of cannabis use and functional impairment including demographic characteristics, socioeconomic status, trait coping style, age of onset of several risk behaviors, current use of common addictive substances, level of functional impairment, and current psychiatric symptom severity. Results showed that approximately half of the participants were at moderate to high risk for a substance use disorder, and just over 4% appeared to have a primary substance use disorder. They also suggested an association between cannabis use and gender (male), age of first cannabis use, recent cigarette use, and functional impairment. Independently, functional impairment was predicted by inattentive coping style, depression severity, and total cannabis use score. These results confirm a high risk for addictive disorders and an association between cannabis use and functional impairment in this sample. These results support the need for substance use treatment programs to optimize care wherever youth with primary mood and/or anxiety concerns are seen.
References
1. Lubman DI, Allen NB, Rogers N, Cementon E, Bonomo Y. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord 2007;103: 105–12.10.1016/j.jad.2007.01.011Search in Google Scholar PubMed
2. Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, et al. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 2011;131:233–42.10.1016/j.jad.2010.12.014Search in Google Scholar PubMed
3. Liang W, Chikritzhs T, Lenton S. Affective disorders and anxiety disorders predict the risk of drug harmful use and dependence. Addiction 2011;106:1126–34.10.1111/j.1360-0443.2011.03362.xSearch in Google Scholar PubMed
4. Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, et al. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment. Aust NZ J Psychiatry 2007;41:896–902.10.1080/00048670701634986Search in Google Scholar PubMed
5. Seguin M, Renaud J, Lesage A, Robert M, Turecki G. Youth and young adult suicide: a study of life trajectory. J Psychiatr Res 2011;45:863–70.10.1016/j.jpsychires.2011.05.005Search in Google Scholar PubMed
6. Price C, Hemmingsson T, Lewis G, Zammit S, Allebeck P. Cannabis and suicide: longitudinal study. Br J Psychiatry 2009;195:492–7.10.1192/bjp.bp.109.065227Search in Google Scholar PubMed
7. Lagerberg TV, Sundet K, Aminoff SR, Berg AO, Ringen PA, et al. Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2011;261:397–405.10.1007/s00406-011-0188-4Search in Google Scholar PubMed PubMed Central
8. Wittchen HU, Frohlich C, Behrendt S, Gunther A, Rehm J, et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007;88(Suppl 1):S60–70.10.1016/j.drugalcdep.2006.12.013Search in Google Scholar PubMed
9. Henquet C, Krabbendam L, de Graaf R, ten Have M, van Os J. Cannabis use and expression of mania in the general population. J Affect Disord 2006;95:103–10.10.1016/j.jad.2006.05.002Search in Google Scholar PubMed
10. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, et al. Cannabis use and mental health in young people: cohort study. Br Med J 2002;325:1195–8.10.1136/bmj.325.7374.1195Search in Google Scholar PubMed PubMed Central
11. van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 2007;102:1251–60.10.1111/j.1360-0443.2007.01875.xSearch in Google Scholar PubMed
12. Paglia-Boak A, Adlaf EM, Mann RE. Drug use among Ontario students, 1977–2011: OSDUHS highlights. 2011; CAMH research document series no. 33. Available from: http://www.camh.ca/en/research/news_and_publications/ontario-student-drug-use-and-health-survey/Documents/2011%20OSDUHS%20Docs/2011OSDUHS_Highlights_DrugUseReport.pdf. Accessed on 22 August, 2012.Search in Google Scholar
13. US Department of Health and Human Services. Drug facts. Atlanta, GA: US Department of Health and Human Services, 2012. Available from: http://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends. Accessed on 22 August, 2012.Search in Google Scholar
14. DeGarmo DS, Forgatch MS, Martinez CR Jr. Parenting of divorced mothers as a link between social status and boys’ academic outcomes: unpacking the effects of socioeconomic status. Child Dev 1999;70:1231–45.10.1111/1467-8624.00089Search in Google Scholar PubMed
15. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.10.1037/t00742-000Search in Google Scholar
16. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.Search in Google Scholar
17. Gross JJ, John OP. Individual differences in two emotion regulation preocesses: implications for affect, relationships, and well-being. J Pers Soc Psychol 2003;85:348–62.10.1037/0022-3514.85.2.348Search in Google Scholar PubMed
18. Kessler RC, Adler L, Ames M, Demler O, Faraone S, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245–56.10.1017/S0033291704002892Search in Google Scholar
19. National Institute of Drug Abuse. Screening for drug use in general medical settings: resource guide. National Institute of Drug Abuse, 2009. Available at: http://www.drugabuse.gov/publications/resource-guide. Accessed on 15 April, 2012.Search in Google Scholar
20. Sheehan DV. The anxiety disease. New York, NY: Charles Scribner, 1983.Search in Google Scholar
21. Brener ND, Collins JL, Kann L, Warren CW, Williams BI. Reliability of the youth risk behavior survey questionnaire. Am J Epidemiol 1995;141:575–80.10.1093/oxfordjournals.aje.a117473Search in Google Scholar PubMed
22. Gross JJ. Emotion regulation: affective, cognitive, and social consequences. Psychophysiology 2002;39:281–91.10.1017/S0048577201393198Search in Google Scholar
23. IBM. IBM SPSS statistics v. 20.0.0. Somers, NY: An IBM Company, 2011.Search in Google Scholar
24. Lawrence D, Considine J, Mitrou F, Zubrick SR. Anxiety disorders and cigarette smoking: results from the Australian Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2010;44:520–7.Search in Google Scholar
25. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 2009;9:285.10.1186/1471-2458-9-285Search in Google Scholar PubMed PubMed Central
26. Lawrence D, Mitrou F, Zubrick SR. Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005. BMC Public Health 2011;11:256.10.1186/1471-2458-11-256Search in Google Scholar PubMed PubMed Central
27. US Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, 2012.Search in Google Scholar
©2013 by Walter de Gruyter Berlin Boston
